PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Inari Medical, Inc. (NARI)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US45332Y1091

CUSIP

45332Y109

Sector

Healthcare

IPO Date

May 22, 2020

Highlights

Market Cap

$3.29B

EPS (TTM)

-$1.35

Total Revenue (TTM)

$574.50M

Gross Profit (TTM)

$494.08M

EBITDA (TTM)

-$36.16M

Year Range

$36.73 - $66.61

Target Price

$64.38

Short %

6.30%

Short Ratio

3.32

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
NARI vs. IMVT NARI vs. VOO NARI vs. LNTH
Popular comparisons:
NARI vs. IMVT NARI vs. VOO NARI vs. LNTH

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Inari Medical, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%20.00%40.00%60.00%80.00%100.00%JulyAugustSeptemberOctoberNovemberDecember
27.99%
98.52%
NARI (Inari Medical, Inc.)
Benchmark (^GSPC)

Returns By Period

Inari Medical, Inc. had a return of -16.19% year-to-date (YTD) and -13.53% in the last 12 months.


NARI

YTD

-16.19%

1M

6.75%

6M

17.87%

1Y

-13.53%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

24.66%

1M

0.49%

6M

8.64%

1Y

26.56%

5Y*

13.06%

10Y*

11.10%

Monthly Returns

The table below presents the monthly returns of NARI, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-12.28%-19.02%4.03%-22.18%33.90%-3.70%-3.30%-7.15%-4.60%17.36%7.27%-16.19%
2023-10.24%-1.38%9.74%7.58%-9.06%-3.74%-1.84%16.73%-1.83%-7.17%-1.68%8.76%2.14%
2022-19.40%19.60%3.02%-10.97%-18.46%3.33%14.11%-10.61%4.74%5.91%-4.35%-13.62%-30.36%
20219.31%9.62%2.29%6.81%-23.92%7.28%-3.74%-8.83%-0.93%11.62%-8.82%10.58%4.56%
20203.51%10.09%16.06%42.19%-13.66%-4.09%4.34%26.38%105.34%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of NARI is 33, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of NARI is 3333
Overall Rank
The Sharpe Ratio Rank of NARI is 3232
Sharpe Ratio Rank
The Sortino Ratio Rank of NARI is 3131
Sortino Ratio Rank
The Omega Ratio Rank of NARI is 3131
Omega Ratio Rank
The Calmar Ratio Rank of NARI is 3434
Calmar Ratio Rank
The Martin Ratio Rank of NARI is 3737
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Inari Medical, Inc. (NARI) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for NARI, currently valued at -0.33, compared to the broader market-4.00-2.000.002.00-0.332.12
The chart of Sortino ratio for NARI, currently valued at -0.14, compared to the broader market-4.00-2.000.002.004.00-0.142.83
The chart of Omega ratio for NARI, currently valued at 0.98, compared to the broader market0.501.001.502.000.981.39
The chart of Calmar ratio for NARI, currently valued at -0.24, compared to the broader market0.002.004.006.00-0.243.13
The chart of Martin ratio for NARI, currently valued at -0.61, compared to the broader market0.0010.0020.00-0.6113.67
NARI
^GSPC

The current Inari Medical, Inc. Sharpe ratio is -0.33. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Inari Medical, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.33
1.83
NARI (Inari Medical, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Inari Medical, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-56.79%
-3.66%
NARI (Inari Medical, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Inari Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Inari Medical, Inc. was 70.53%, occurring on Apr 23, 2024. The portfolio has not yet recovered.

The current Inari Medical, Inc. drawdown is 56.79%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-70.53%Mar 12, 2021784Apr 23, 2024
-27.5%Aug 31, 202042Oct 28, 202041Dec 28, 202083
-23.92%Feb 22, 202111Mar 8, 20213Mar 11, 202114
-15.57%Jan 26, 20212Jan 27, 20216Feb 4, 20218
-11.38%Jun 4, 202014Jun 23, 202012Jul 10, 202026

Volatility

Volatility Chart

The current Inari Medical, Inc. volatility is 10.99%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
10.99%
3.62%
NARI (Inari Medical, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Inari Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Inari Medical, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab